Effectiveness Differences of Ranibizumab and Aflibercept Action in the Treatment of Diabetic Retinopathy
CONCLUSION: Both vitreous cavity injections of LU and AF can effectively reduce the expression of vascular-related factors in the atrial fluid of DR patients, but AF has a more significant inhibitory effect on the level of inflammatory factors in patients in the short term after treatment.PMID:37820680 (Source: Alternative Therapies in Health and Medicine)
Source: Alternative Therapies in Health and Medicine - October 11, 2023 Category: Complementary Medicine Authors: Xiaoli Ma Nannan Ma Qianqian Zhang Yonghong Wang Haixia Sun Zhenyuan Yang Source Type: research
Effectiveness Differences of Ranibizumab and Aflibercept Action in the Treatment of Diabetic Retinopathy
CONCLUSION: Both vitreous cavity injections of LU and AF can effectively reduce the expression of vascular-related factors in the atrial fluid of DR patients, but AF has a more significant inhibitory effect on the level of inflammatory factors in patients in the short term after treatment.PMID:37820680 (Source: Alternative Therapies in Health and Medicine)
Source: Alternative Therapies in Health and Medicine - October 11, 2023 Category: Complementary Medicine Authors: Xiaoli Ma Nannan Ma Qianqian Zhang Yonghong Wang Haixia Sun Zhenyuan Yang Source Type: research
Effectiveness Differences of Ranibizumab and Aflibercept Action in the Treatment of Diabetic Retinopathy
CONCLUSION: Both vitreous cavity injections of LU and AF can effectively reduce the expression of vascular-related factors in the atrial fluid of DR patients, but AF has a more significant inhibitory effect on the level of inflammatory factors in patients in the short term after treatment.PMID:37820680 (Source: Alternative Therapies in Health and Medicine)
Source: Alternative Therapies in Health and Medicine - October 11, 2023 Category: Complementary Medicine Authors: Xiaoli Ma Nannan Ma Qianqian Zhang Yonghong Wang Haixia Sun Zhenyuan Yang Source Type: research
Effectiveness Differences of Ranibizumab and Aflibercept Action in the Treatment of Diabetic Retinopathy
CONCLUSION: Both vitreous cavity injections of LU and AF can effectively reduce the expression of vascular-related factors in the atrial fluid of DR patients, but AF has a more significant inhibitory effect on the level of inflammatory factors in patients in the short term after treatment.PMID:37820680 (Source: Alternative Therapies in Health and Medicine)
Source: Alternative Therapies in Health and Medicine - October 11, 2023 Category: Complementary Medicine Authors: Xiaoli Ma Nannan Ma Qianqian Zhang Yonghong Wang Haixia Sun Zhenyuan Yang Source Type: research
Effectiveness Differences of Ranibizumab and Aflibercept Action in the Treatment of Diabetic Retinopathy
CONCLUSION: Both vitreous cavity injections of LU and AF can effectively reduce the expression of vascular-related factors in the atrial fluid of DR patients, but AF has a more significant inhibitory effect on the level of inflammatory factors in patients in the short term after treatment.PMID:37820680 (Source: Alternative Therapies in Health and Medicine)
Source: Alternative Therapies in Health and Medicine - October 11, 2023 Category: Complementary Medicine Authors: Xiaoli Ma Nannan Ma Qianqian Zhang Yonghong Wang Haixia Sun Zhenyuan Yang Source Type: research
The efficacy and ocular safety following aflibercept, conbercept, ranibizumab, bevacizumab, and laser for retinopathy of prematurity: a systematic review and meta-analysis
ConclusionsAnti-VEGF was associated with higher retreatment and lesser incidence of myopia as compared to laser. Laser therapy was linked to more complications like retinal detachment and myopia. Ranibizumab exhibited higher recurrence and retreatment rates compared to bevacizumab, aflibercept, and conbercept. (Source: Italian Journal of Pediatrics)
Source: Italian Journal of Pediatrics - October 9, 2023 Category: Pediatrics Source Type: research
The efficacy and ocular safety following aflibercept, conbercept, ranibizumab, bevacizumab, and laser for retinopathy of prematurity: a systematic review and meta-analysis
Retinopathy of prematurity (ROP) is typically treated with laser photocoagulation and/or intravitreal anti-vascular endothelial growth factor (anti-VEGF). To the best of our knowledge, most systematic reviews ... (Source: Italian Journal of Pediatrics)
Source: Italian Journal of Pediatrics - October 9, 2023 Category: Pediatrics Authors: Jing Chen, Qingfei Hao, Jing Zhang, Yanna Du, Haoming Chen and Xiuyong Cheng Tags: Research Source Type: research
Diversity when interpreting evidence in network meta-analyses (NMAs) on similar topics: an example case of NMAs on diabetic macular oedema
ConclusionsA closer inspection of each of these trials shows how the methods, including the searches and analyses, all differ, but the findings, although presented differently and sometimes interpreted differently, were similar. (Source: Systematic Reviews)
Source: Systematic Reviews - October 7, 2023 Category: International Medicine & Public Health Source Type: research
Acute Kidney Injury from Intravitreal Anti-vascular Endothelial Growth Factor Drugs: A Systematic Review and Meta-analysis of Randomized Controlled Trials
ConclusionsIntravitreal anti-VEGF drugs were not associated with an acute kidney injury risk, regardless of which anti-VEGF drugs (aflibercept or ranibizumab) or retinal diseases (age-related macular degeneration, diabetic retinopathy/diabetic macular edema, or retinal vein occlusion) were involved.Systematic Review Protocol RegistrationPROSPERO CRD42021267854. (Source: BioDrugs)
Source: BioDrugs - September 7, 2023 Category: Drugs & Pharmacology Source Type: research
A real-world disproportionality analysis of anti-VEGF drugs from the FDA Adverse Event Reporting System
CONCLUSIONS: Our findings support the associations between anti-VEGF drugs and ocular AEs, cardiac AEs, and central nervous AEs. After intravitreal injection, attention should not only be paid to ocular symptoms, but also to systemic symptoms.PMID:37665052 | DOI:10.1080/14740338.2023.2250717 (Source: Expert Opinion on Drug Safety)
Source: Expert Opinion on Drug Safety - September 4, 2023 Category: Drugs & Pharmacology Authors: Ruishan Zhou Peiwen Lu Mingxiu He Junheng Chen Yiyang Shi Fangfang Han Yongming Cai Source Type: research
Effect of Laser Panretinal Photocoagulation Combined with Lucentis on Long-Term Visual Acuity of Patients with Retinal Arterial Macroaneurysm
CONCLUSION: Laser panretinal photocoagulation combined with lucentis can deliver with reduced incidence of adverse effects compared to laser panretinal photocoagulation treatment and hence can more effectively contribute to retinal rehabilitation of patients with retinal arterial macroaneurysm.PMID:37632971 (Source: Alternative Therapies in Health and Medicine)
Source: Alternative Therapies in Health and Medicine - August 26, 2023 Category: Complementary Medicine Authors: Sha Liu Yan Wang Source Type: research
Effect of Laser Panretinal Photocoagulation Combined with Lucentis on Long-Term Visual Acuity of Patients with Retinal Arterial Macroaneurysm
CONCLUSION: Laser panretinal photocoagulation combined with lucentis can deliver with reduced incidence of adverse effects compared to laser panretinal photocoagulation treatment and hence can more effectively contribute to retinal rehabilitation of patients with retinal arterial macroaneurysm.PMID:37632971 (Source: Alternative Therapies in Health and Medicine)
Source: Alternative Therapies in Health and Medicine - August 26, 2023 Category: Complementary Medicine Authors: Sha Liu Yan Wang Source Type: research
Effect of Laser Panretinal Photocoagulation Combined with Lucentis on Long-Term Visual Acuity of Patients with Retinal Arterial Macroaneurysm
CONCLUSION: Laser panretinal photocoagulation combined with lucentis can deliver with reduced incidence of adverse effects compared to laser panretinal photocoagulation treatment and hence can more effectively contribute to retinal rehabilitation of patients with retinal arterial macroaneurysm.PMID:37632971 (Source: Alternative Therapies in Health and Medicine)
Source: Alternative Therapies in Health and Medicine - August 26, 2023 Category: Complementary Medicine Authors: Sha Liu Yan Wang Source Type: research
